Trading Signals: TGTX Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 14, 2022)(TG Therapeutics Inc)
| TGTX latest price $7.2200 (3.88%) ($7.2200 - $7.2200) on Fri. Sep. 9, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 6.79% (three month average) | RSI | 54 | Latest Price | $7.2200(3.88%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | TGTX declines -0.5% a day on average for past five trading days. | Weekly Trend | TGTX declines -2.9% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support TGTX advance at 0% a week (0% probability) SPLV(74%) USO(-35%) UUP(-64%) TIP(20%) TBT(-137%) | Factors Impacting TGTX price | TGTX will decline at least -3.395% in a week (0% probabilities). LQD(58%) BNDX(25%) CEMB(53%) EDOC(12%) BND(59%) | | | | | Relative Volatility | | | | Market Trend Strength | -3.395% (StdDev 6.79%) | Hourly BBV | 1.4 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $-9.23(-227.84%) | 5 Day Moving Average | $6.7(7.76%) | 10 Day Moving Average | $6.82(5.87%) | 20 Day Moving Average | $7.12(1.4%) | To recent high | -14.3% | To recent low | 93.3% | Market Cap | $914m | | | | TG Therapeutics, Inc. is a biopharmaceutical company, which engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1101, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in New York, NY. |